Patents applications published 13 January 2010

Published: 23-Feb-2010
Patient Experience

  • Polymers having covalently bound antibiotic agents
    Ethicon 2141988*


    • Polymers having covalently bound antibiotic agents
      Ethicon 2141988*

    • Compsns and methods for prophylaxis and treatment of addictions
      Omeros 2141989*

    • 11btea-HSD1 active compounds
      High Point Pharmaceuticals 2141990*

    • Combination therapy for the treatment of lower urinary tract symptoms
      Merck 2141992*

    • Antimicrobial compsns
      Clariant Finance 2141993*

    • Multi-ring compounds and uses thereof
      Avalon Pharmaceuticals 2141994*

    • Compsns and methods for protecting cells from toxic exposures
      Perscitus Biosciences 2141995*

    • Methods for preventing or treating infectious diseases using gallium compounds
      Sideromics 2141996*

    • Constitutive expression of costimulatory ligands on adoptively transferred T-lymphocytes
      Memorial Sloan-Kettering Cancer Centre 2141997*

    • Acoustically sensitive drug delivery particles
      Epitarget 2142167*

    • Means for the application of active substances in the ear canal of a patient
      Illi, Oscar; Feldmann, Clarence 2142168*

    • Aqueous pharmaceutical preparation
      Merck Patent 2142169*

    • A method of producing fast dissolving tablets
      The Royal College of Surgeons in Ireland 2142170*

    • Packaged film dosage unit containing a complexate
      MonoSol 2142172*

    • High dose compsn of ursodeoxycholic acid
      Disphar International 2142173*

    • Stable aqueous G-CSFformulations
      Sandoz 2142174*

    • Pharmaceutical compsns of diclofenac and misoprostol
      Wockhardt Research Centre; Gundu, Ramakant; Jain, Girish; Murali, Narayanan; Dabre, Rahul; Kodgule, Mandar 2142175*

    • Compsns and methods for transmucosal delivery of domperidone
      Aronchick, Craig 2142176*

    • Freezable unit dosage delivery system and method of preparation
      Culligan, Christopher; Sankey, Jay; Smith, Neil; Hart, Rob 2142177*

    • Pharmaceutical compsns and process
      F Hoffmann-La Roche 2142178*

    • Topical dermal delivery device for nitric oxide delivery
      NOLabs 2142179*

    • Compsns comprising terpene compounds and methods for inhibiting nerve transmission
      Origin BioMed 2142182*

    • Methods and compsns comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
      Sepracor 2142183*

    • Use of S1P receptor modulator
      Novartis 2142184*

    • Droxidopa and pharmaceutical compsn thereof for the treatment of neurally mediated hypotension
      Chelsea Therapeutics 2142185*

    • Use of oligomers of lactic acid in the treatment of gynaecological disorders
      Laccure 2142186*

    • Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof
      Pierre Fabre Medicament 2142187*

    • Methods of suppressing TPinhibition
      Elan Pharmaceuticals; Provost, Fellows and Scholars of the College of the Undivided Trinity of Queen Elizabeth near Dublin 2142188*

    • Methods and compsns for intraocular adminstration to treat ocular conditions
      Allergan 2142189*

    • Use of HDACinhibitors for the treatment of gastrointestinal cancers
      Novartis 2142190*

    • Use of biotin to prevent photoaging
      DSM 2142191*

    • Compsns and kits for treating influenza
      Adamas Pharmaceuticals 2142192*

    • 1-[2-(2,4-dimethylphenylsulphanyl)-phenyl]-piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
      H Lundbeck 2142193*

    • Mineralocorticoid receptor antagonists
      NV Organon 2142194*

    • Compsn for promoting the maintenance and function of muscle-specific progenitor cells
      Iovate T&P 2142195*

    • Surfactant lipids, compsns thereof, and uses thereof
      National Jewish Health 2142196*

    • Method for the treatment of Fabry disease using pharmaceutical chaperones
      Amicus Therapeutics 2142197*

    • Reduction of the risk of diarrhoea
      Nestec 2142198*

    • A process to activate extracts derived from living organisms using long-wave UV irradiation and compsns comprising said extract
      Medizinische Universitaet Wien 2142199*

    • Use of cocoa extract
      Barry Callebaut 2142201*

    • Cleome spinosa extract used in pharmaceutical preparations and cosmetic compsns
      Pierre Fabre Dermo-Cosmetique 2142202*

    • Cocoa extract and use thereof
      Barry Callebaut 2142203*

    • Novel use of cocoa extract
      Barry Callebaut 2142204*

    • Compsns and method for increasing vascularisation
      Biogen Idec; INSERM(Institut National de la Sante et de la Recherche Medicale) 2142205*

    • Method of treating ischaemic disorders
      The Cleveland Clinic Foundation 2142206*

    • Pharmaceutical formulations of GHRHmolecules
      Theratechnologies 2142207*

    • Lung volume reduction therapy using crosslinked biopolymers
      Aeris Therapeutics 2142208*

    • Aerosol dispersions of particles with active pharmaceutical ingredients
      Particle Sciences 2142209*

    • Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
      Immutep, INSERM(Institut National de la Sante et de la Recherche Medicale) 2142210*

    • Vaccine
      GlaxoSmithKline Biologicals 2142211*

    • Method of eliciting immune response with a modified MVAviral HIV-1 vector
      International AIDSVaccine Initiative 2142212*

    • Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof
      NovelMed Therapeutics 2142213*

    • Anti-IGEantibodies
      Amgen Fremont; Pfizer 2142214*

    • Combination therapy for the treatment of HCVinfection
      Vertex Pharmaceuticals 2142215*

    • Particle formulation and uses thereof
      Particle Sciences 2142216*
    See more

    You may also like

    Digital

    Pharma cybersecurity challenges: a holistic prescription

    Read more
    The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape

    Trending Articles

    1. Pfizer wins battle over Viagra trademark Energy drinks brand Viaguara cannot be registered as an EU trademark
    2. Patent applications published 7 July 2010 Selected patent applications from the weekly European Patents Bulletin
    3. Genmab says GSK has settled patent case with Genentech Concerning two US patents for ofatumumbab
    4. Boehringer Ingelheim suffers Spiriva patent blow in India Indian patent office has revoked a patent granted for tiotropium bromide monohydrate under the Spiriva brand, paving the way for Cipla to continue selling its generic version in the Indian market
    5. Phillips-Medisize acquires mini-tablet dispenser patent The US company has acquired exclusive ownership of the patent from a global pharmaceutical company and expects to make the product available by early 2020

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Digital

    Pharma cybersecurity challenges: a holistic prescription

    The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape
    Regulatory

    Pharmaseal reaches milestone in crowdfunding campaign

    The company was first founded in 2016
    Patient Experience

    Ilya Pharma awarded engineered lactic acid bacterial strain patent

    The patent covers the use of engineered lactic acid bacterial strains for all human and animal wounds, not just skin
    Pharmaceutical

    A card in the competition for COVID-19 drug supply

    The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19, reports Paul England, Senior Professional Support Lawyer at Taylor Wessing
    Ingredients

    Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

    Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced with a large surface area and a range of pore sizes
    Ingredients

    VistaGen and Nuformix agree to develop cocrystalline forms of AV-101

    The drug for treatment of multiple CNS conditions will be reformed into a novel patentable form to potentially improve delivery and give more intellectual property protection
    Digital

    Documentation complexity at crisis point?

    Do we focus too much on the paperwork, to the detriment of product and patients? Has documentation become so complex it’s become a dangerous distraction and your biggest risk? by Martin Lush
    Subscribe now